Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment.
<h4>Background</h4>Invariant Natural Killer T (iNKT) cells represent a determinant in the course of infections and diseases, however, their role in the pathogenesis of non-infectious co-morbidities in HIV-positive patients is unknown.<h4>Methods</h4>Flow cytometry was used to...
Guardado en:
Autores principales: | Camilla Tincati, Matteo Basilissi, Elisabetta Sinigaglia, Esther Merlini, Giovanni Carpani, Antonella d'Arminio Monforte, Giulia Marchetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebf86645bb9b4745b57016c48926c21f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice
por: Camilla Falcinella, et al.
Publicado: (2021) -
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.
por: Matteo Bellone, et al.
Publicado: (2010) -
Histone deacetylase 3 is required for iNKT cell development
por: Puspa Thapa, et al.
Publicado: (2017) -
Regulation of the terminal maturation of iNKT cells by mediator complex subunit 23
por: Yu Xu, et al.
Publicado: (2018) -
TCR signal strength controls thymic differentiation of iNKT cell subsets
por: Kathryn D. Tuttle, et al.
Publicado: (2018)